- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02056652
Prevention of Preterm Birth With a Pessary in Singleton Gestations (PoPPS)
April 27, 2018 updated by: University of Pennsylvania
Preterm birth (PTB) is associated with over one million infant deaths annually worldwide.
The incidence of PTB in the United States is 11.5% with more than 500,000 deliveries occurring at less than 37 weeks gestation annually.
The rate of PTB in the United States increased to 12.8% in 2006, and remains high compared to almost all other developed countries, despite the introduction of many public health and medical interventions designed to delay PTB.
Weekly treatment with 17-alpha hydroxyprogesterone caproate beginning at 16-20 weeks gestation has been shown to significantly reduce the risk of PTB and is currently recommended for women who experienced spontaneous PTB in a prior pregnancy.
However, a strategy for the prevention of spontaneous PTBs in which therapeutic intervention is restricted to women with a previous PTB is likely to have a small effect on the overall rate of prematurity since only about 10% of spontaneous PTBs arise in women with such a history.
A major reduction in rates of mortality and morbidity in premature babies will only be achieved with increased precision in the identification of women at risk of spontaneous PTB and through the development of an effective prevention for this complication.
Transvaginal ultrasound measurement of cervical length is a reliable screening test for prediction of PTB.
Although treatment with vaginal progesterone is effective in decreasing PTB in women with a short cervix, over 30% of women still experience premature delivery and many women find daily administration of progesterone to be challenging.
Preliminary studies have suggested that use of an intravaginal pessary may be effective in preventing PTB.
If effective this approach would be particularly appealing because of the wide availability of pessaries, ease of use, and low cost.
Unfortunately, existing studies are inadequate to confirm effectiveness; a well designed, properly powered, prospective randomized trial is warranted prior to widespread implementation in clinical practice.
We propose such a trial to study the effectiveness of the pessary in decreasing the incidence of PTB in an inner city Philadelphia population.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
122
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Danville, Pennsylvania, United States, 17822
- Geisinger Medical Center
-
Philadelphia, Pennsylvania, United States, 19104
- Hospital of the University of Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19107
- Thomas Jefferson University Hospital
-
Philadelphia, Pennsylvania, United States, 19107
- Pennsylvania Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- 18-50 years of age
- Singleton pregnancy (limits the participants to female gender)
- Short cervical length (less than or equal to 25 mm) on second trimester ultrasound at 18-23 6/7 weeks gestation
Exclusion Criteria:
- Multiple gestation
- Prior spontaneous preterm birth 16-36 6/7 weeks
- Ruptured membranes
- Lethal fetal structural anomaly
- Fetal chromosomal abnormality
- Cerclage in place (or planned placement)
- Vaginal bleeding
- Suspicion of chorioamnionitis
- Ballooning of membranes outside the cervix into the vagina or CL = 0 mm on transvaginal ultrasound
- Painful regular uterine contractions
- Placenta previa
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: No pessary
No pessary will be used.
Subjects will receive standard obstetrical management
|
|
Experimental: Pessary
Use of the Bioteque cup pessary.
Pessary will be placed between 18 and 23 6/7 weeks gestation, and will be removed during the 37th week of pregnancy (or earlier, if indicated)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Subjects Experiencing Preterm Birth
Time Frame: Before 37 weeks gestation (20 0/7 - 36 6/7 weeks)
|
Birth before 37 weeks gestation was captured.
|
Before 37 weeks gestation (20 0/7 - 36 6/7 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Average Birth Weight of Babies Born on Trial
Time Frame: Time of delivery
|
The birth weights of babies born in the pessary group was compared to those born in the no pessary group
|
Time of delivery
|
Number of Participants That Experienced Spontaneous Preterm Births on Trial
Time Frame: Before 37 weeks gestation
|
The number of spontaneous births that occurred in participants on trial before 37 weeks was captured.
|
Before 37 weeks gestation
|
Number of Participants Experiencing Spontaneous Rupture of Membranes
Time Frame: Less than 34 weeks gestation
|
Rupture of membranes before 34 weeks gestation was captured in each group.
|
Less than 34 weeks gestation
|
Number of Subjects Experiencing Neonatal Death
Time Frame: Between birth and 28 days of age
|
Number of participants who experienced neonatal deaths from birth to day 28 was captured for each group.
|
Between birth and 28 days of age
|
Number of Subjects Experiencing Chorioamnionitis
Time Frame: Time of delivery
|
The AE of Chorioamnionitis was captured for each group.
|
Time of delivery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Lorraine Dugoff, MD, University of Pennsylvania
- Principal Investigator: Vincenzo Berghella, MD, Thomas Jefferson University
- Principal Investigator: Jack Ludmir, MD, University of Pennsylvania
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2014
Primary Completion (Actual)
September 1, 2016
Study Completion (Actual)
November 1, 2016
Study Registration Dates
First Submitted
February 4, 2014
First Submitted That Met QC Criteria
February 4, 2014
First Posted (Estimate)
February 6, 2014
Study Record Updates
Last Update Posted (Actual)
May 29, 2018
Last Update Submitted That Met QC Criteria
April 27, 2018
Last Verified
April 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 817797
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preterm Birth
-
e-Bio CorpRecruitingPreterm Labor | PreTerm Birth | Preterm Labor With Delivery NosUnited States
-
Chelsea and Westminster NHS Foundation TrustSPD Development Company Limited; Borne CharityRecruitingPreterm Birth | Preterm Labor | Preterm Birth Complication | Preterm Premature Rupture of Membrane | Preterm PregnancyUnited Kingdom
-
Thomas Jefferson UniversityCompleted
-
Cairo UniversityCompleted
-
University of OklahomaCompletedPreTerm Birth | PreTerm NeonateUnited States
-
PreTeL, IncDuke University; University of RochesterRecruitingPreterm Birth | Threatened Preterm Labor | PreTerm LaborUnited States
-
Federico II UniversityRecruiting
-
University of OxfordShoklo Malaria Research UnitCompleted
-
Eunice Kennedy Shriver National Institute of Child...CompletedPregnancy | Preterm Birth | Preterm LaborUnited States
-
University Hospital Inselspital, BerneAmniSure International LLCCompletedPreterm Birth | Preterm LabourSwitzerland
Clinical Trials on Bioteque cup pessary
-
University of PennsylvaniaCompletedPremature Birth | Short CervixUnited States
-
Medstar Health Research InstituteWithdrawn
-
Zeynep Kamil Maternity and Pediatric Research and...Unknown
-
University of California, San FranciscoEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingFistula | Obstetric Fistula | Fistula, Urinary | Fistula, VaginalGhana
-
Oslo University HospitalUniversity of OsloCompleted
-
Sahlgrenska University Hospital, SwedenCompletedProsthesis LooseningSweden
-
Bürgerhospital FrankfurtNot yet recruitingPremature Birth | Preterm BirthGermany, Spain, Australia, Greece
-
Bürgerhospital FrankfurtNot yet recruitingPremature Birth | Preterm BirthGermany, Spain, Australia, Greece
-
Federico II UniversityTerminated
-
University of GuelphAgriculture and Agri-Food Canada; Saskatchewan Pulse GrowersCompleted